# A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases

> **NCT02133677** · PHASE2 · UNKNOWN · sponsor: **Far Eastern Memorial Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Lung Cancer and Breast Cancer Patients With Brain Metastases

## Interventions

- **DRUG:** temozolomide 100mg

## Key facts

- **NCT ID:** NCT02133677
- **Lead sponsor:** Far Eastern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2015-05
- **Final completion:** 2016-05
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2014-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02133677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02133677, "A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02133677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*